Blog
RSS FeedPosted by Michael Wonder on 30 Nov 2020
New Zealand Pharmaceutical Schedule - 1 December 2020
1 December 2020 - The December 2020 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Nov 2020
GPs tell inquest they were unaware PHARMAC changed their patients' epilepsy drugs
30 November 2020 - Two GPs caring for patients who died after switching brands of an epilepsy drug say they were ...
Posted by Michael Wonder on 29 Nov 2020
Sudden epilepsy deaths: grieving mum speaks out ahead of coronial inquest
28 November 2020 - Michelle Townes believes her 31-year-old son died because the brand of his Government funded drug was switched. ...
Posted by Michael Wonder on 29 Nov 2020
Drug change not ruled out as factor in epilepsy death, neurologist's report says
29 November 2020 - The first official recognition that changing brands of epilepsy drugs may have been a factor in at ...
Posted by Michael Wonder on 27 Nov 2020
Dr Crawshaw takes over as PHARMAC’s medical director after COVID challenges in the UK
27 November 2020 - PHARMAC is pleased to announce that Dr Shirley Crawshaw, seven months after she was appointed, has arrived ...
Posted by Michael Wonder on 27 Nov 2020
Proposal for funded multiple sclerosis treatments
27 November 2020 - PHARMAC is proposing some changes to the way that multiple sclerosis treatments are funded, as well ...
Posted by Michael Wonder on 26 Nov 2020
Bowel disease patients to march on PHARMAC and Parliament to present 30,000+ signature petition
27 November 2020 - On 2 December 2020, Crohn’s and Colitis NZ will lead a march of patients, supporters and medical ...
Posted by Michael Wonder on 24 Nov 2020
'Disappointing' delay for new type 2 diabetes drugs that stop kidney failure and save lives
24 November 2020 - Kim Dennis is one of few New Zealanders who knows what it’s like to manage their ...
Posted by Michael Wonder on 24 Nov 2020
GPs frustrated by PHARMAC’s lack of progress on better meds for type 2 diabetics
24 November 2020 - PHARMAC has put the brakes on two new medications that would greatly improve treatment options for ...
Posted by Michael Wonder on 23 Nov 2020
Woman trying to raise $110,000 a month for life-extending breast cancer treatment
23 November 2020 - “Pay up or die” is the choice for a woman in her 30s trying to raise ...
Posted by Michael Wonder on 23 Nov 2020
Ethinyloestradiol 20 mcg with desogestrel 150 mcg and 7 inert tablets (Mercilon 28)
23 November 2020 - Ethinyloestradiol 20 mcg with desogestrel 150 mcg and 7 inert tablets (Mercilon 28) will be fully funded ...
Posted by Michael Wonder on 23 Nov 2020
Funding changes to dornase alfa for cystic fibrosis
23 November 2020 - From 1 December 2020 dornase alfa will be listed in the Community and the Hospital Medicines List ...
Posted by Michael Wonder on 22 Nov 2020
Device vital for monitoring diabetes should be funded 'immediately'
23 November 2020 - Ben Hoy and Anne Marie Guiney would not be able to cope with having two type ...
Posted by Michael Wonder on 17 Nov 2020
PHARMAC and Diabetes Foundation Aotearoa locked in stand-off over drug funding decision
17 November 2020 - The Diabetes Foundation Aotearoa is calling on drug funding agency PHARMAC to release the submissions it ...
Posted by Michael Wonder on 15 Nov 2020
New drug gives 'normal life' to haemophiliac who thought he would never study, surf or be on stage
15 November 2020 - Performing on stage, going to university and surfing are things Andrew Scott never thought he would ...